Latest Us Market News

Smart Parking Limited grew its ANPR sites by 17% in Q3 FY26 and increased parking breach notices by 19%, leveraging acquisitions and AI technology to expand across Europe and New Zealand.

Titomic Limited is set to shift its corporate domicile from Australia to the United States through a scheme of arrangement, aiming to deepen its US defense market presence and access broader capital pools while maintaining its ASX listing.

Fluence Corporation has landed a $3.7 million contract to build a high-capacity water treatment plant in Texas, aiming to reduce industrial reliance on municipal water amid ongoing drought conditions.

OD6 Metals has pinpointed the historically noted Big Jim Fluorspar Lode within its Quinn Project, revealing grades up to 98.6% CaF2 and defining a new, substantial drill target in a district-scale system.

Ionic Rare Earths’ subsidiary Ionic Technologies has led a pioneering UK project demonstrating a fully circular supply chain for electric vehicle magnets using 100% recycled rare earth oxides, achieving performance parity with primary materials and advancing UK critical minerals goals.

Amaero Ltd has sent out its Scheme Booklet for the upcoming June 5, 2026 meetings where shareholders will vote on the company’s re-domiciliation to the US and approve new incentive options.

Neuren Pharmaceuticals saw a 20% jump in Q1 2026 DAYBUE net sales to US$101 million, with royalties up 23%. The Japan trofinetide trial has been fast-tracked, and the new powder formulation DAYBUE STIX gains early traction.

Zip Co’s April update highlights robust US and ANZ market expansion, with total transaction volume surging and credit losses forecast below 1.75%. The company reconfirms FY26 guidance, underpinned by AI-driven underwriting and new subscription offerings.

Acusensus Limited maintains its FY26 revenue and EBITDA guidance while advancing multiple enforcement programs across the US, UK, New Zealand, and Australia, underpinned by new product developments and international growth.

Noxopharm is gearing up for a pivotal pre-IND meeting with the US FDA, enlisting global CRO Novotech to sharpen its regulatory approach for SOF-SKN, a drug targeting autoimmune skin diseases.

Nova Eye Medical has smashed its US sales record in April 2026, prompting an upgrade to its FY26 sales guidance and marking a milestone with positive operational EBITDA.

Entropy Neurodynamics has bolstered its intellectual property portfolio with a new US provisional patent application for TRP-8803, following compelling Phase 2a data showing a 75% response rate in treatment-resistant IBS patients.